pacDNA
PrivateLast Round
Grant
Jan 17, 2025
Total Funding Raised
$2.99M
Company Overview
pacDNA is a biotechnology company that develops oligonucleotide therapeutics for the treatment of cancer and rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pacDNA Comps
Public and private peers based on sector, stage, and business model.
pacDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2025 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Accelerator | Sep 1, 2022 | ||||
| Grant | Jul 1, 2022 |
pacDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Northeastern University Center for Research Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
$490K grant from Congressionally Directed Medical Research Programs
- Sep 1, 2023
$50K grant received from Northeastern University Center for Research Innovation.
pacDNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about pacDNA's valuation, stock price, and market status.
